Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CytomX Therapeutics, Inc. CTMX

Set alert

Price alert · CTMX

All alert types
2.19 USD -0.04 -1.84%

As of Nov 3, 3:00 PM ET

Bid
2.18 × 2
Ask
2.19 × 2
2.18 Day range 2.32
2.14 52-week range 8.21
YTD
-48.62%
1 year
-44.30%
Open
2.25
Prev close
2.23
Mkt cap
476.11M
Vol
2.45M
Avg vol
3.59M
EPS
-0.51
P/E
0.00
Div yield
0.00%
More statistics
Low
2.18
High
2.32
Forward P/E
-9.74
Beta
2.48
Short ratio
1.78
Inst. own
75.69%
Dividend
0.00
Ex-div date
50-d avg
4.92
200-d avg
3.77
1y target
13.67

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (55)
NameTimeAgo
MACD: Sell SignalNov 3, 10:30 AM4 hours ago
RSI: OverboughtNov 3, 9:35 AM5 hours ago
RSI: OverboughtNov 2, 3:35 PM23 hours ago
SMA: BullishNov 2, 3:30 PM23 hours ago
SMA: BullishNov 2, 3:00 PM1 day ago
MACD: Buy SignalNov 2, 2:55 PM1 day ago
RSI: OversoldNov 2, 1:45 PM1 day ago
MACD: Sell SignalNov 2, 1:30 PM1 day ago
SMA: BearishNov 2, 12:10 PM1 day ago
SMA: BullishNov 2, 12:05 PM1 day ago
MACD: Buy SignalNov 2, 11:35 AM1 day ago
SMA: BearishNov 2, 10:30 AM1 day ago
SMA: BearishNov 2, 10:30 AM1 day ago
SMA: BullishNov 2, 10:20 AM1 day ago
SMA: BullishNov 2, 10:20 AM1 day ago
SMA: BearishNov 2, 10:15 AM1 day ago
SMA: BullishNov 2, 10:10 AM1 day ago
MACD: Sell SignalNov 2, 9:45 AM1 day ago
SMA: BearishNov 2, 9:35 AM1 day ago
RSI: OverboughtOct 30, 3:50 PM4 days ago

Newest 20 of 55.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 13.67 +524.4% upside
Target (low)
11.00
Target (mean)
13.67
Target (high)
17.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 9
  • 3 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CTMX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.11499-0.16291 – -0.0770.27-142.6%4.68M-90.8%8
Next quarter-0.06686-0.15384 – 0.120.000.0%10.47M-43.9%8
Current year-0.41703-0.69321 – -0.193-0.15-178.0%22.17M-70.9%8
Next year-0.47309-0.69872 – -0.166-0.41703-13.4%18.73M-15.5%8

Upgrades and downgrades

The latest rating changes

CTMX analyst upgrades and downgrades
DateFirmActionFromTo
Mar 23, 2026Piper SandlerMaintainedOverweightOverweight
Mar 19, 2026BarclaysMaintainedOverweightOverweight
Mar 18, 2026JefferiesMaintainedBuyBuy
Mar 18, 2026GuggenheimMaintainedBuyBuy
Mar 17, 2026WedbushMaintainedOutperformOutperform
Mar 16, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 16, 2026JP MorganUpgradeNeutralOverweight
Mar 9, 2026GuggenheimReiteratedBuyBuy
Feb 4, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Feb 4, 2026BarclaysMaintainedOverweightOverweight
Jan 20, 2026BarclaysMaintainedOverweightOverweight
Jan 20, 2026GuggenheimInitiated—Buy
Jan 20, 2026Piper SandlerMaintainedOverweightOverweight
Nov 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 21, 2025BarclaysMaintainedOverweightOverweight
Sep 22, 2025Cantor FitzgeraldInitiated—Overweight
Jul 31, 2025OppenheimerInitiated—Outperform
May 20, 2025HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2025Piper SandlerMaintainedOverweightOverweight
May 15, 2025HC Wainwright & Co.UpgradeNeutralBuy
Apr 14, 2025Piper SandlerMaintainedOverweightOverweight
Mar 7, 2025HC Wainwright & Co.ReiteratedNeutralNeutral
Jan 7, 2025HC Wainwright & Co.ReiteratedNeutralNeutral
Nov 11, 2024HC Wainwright & Co.Reiterated—Neutral
Sep 13, 2024HC Wainwright & Co.Reiterated—Neutral
Aug 22, 2024HC Wainwright & Co.Reiterated—Neutral
Jun 27, 2024HC Wainwright & Co.Reiterated—Neutral
May 28, 2024Piper SandlerUpgradeNeutralOverweight
May 9, 2024BMO CapitalMaintainedMarket PerformMarket Perform
May 9, 2024HC Wainwright & Co.Reiterated—Neutral